Approval · Notice of Compliance 940 · 2000
SECTRAL: Notice of Compliance 940
Issued November 14, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 940
- Date
- November 14, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antihypertensive and anti-anginal agent
Products in this notice
Medicinal ingredients
- ACEBUTOLOL HCL 100 MG per TAB
- ACEBUTOLOL HCL 200 MG per TAB
- ACEBUTOLOL HCL 400 MG per TAB